Swiss drugs giant launches 15 products in Kenya
Kenya is the first country to benefit from a portfolio of 15 affordable medicines to treat cardiovascular diseases, diabetes, respiratory illnesses, and breast cancer.
“Novartis and Kenya have a relationship of more than 40 years, so I am delighted that Kenyan patients will be the first to benefit from Novartis Access.
“The successful implementation of the programme in Kenya will be essential to guide the expansion of.... Read more »
Posted on : Wednesday , 21st October 2015


















